| Description | Epcoritamab (GEN3013) is a bispecific IgG1 antibody that redirects T-cells toward CD3×CD20-positive tumor cells, inducing potent T-cell-mediated cytotoxicity against B-cell non-Hodgkin lymphoma (NHL) cell lines [1]. |
| In vitro | Epcoritamab (30 ng/mL) 在健康捐献者的外周血单核细胞 (PBMC) 存在下，能够有效诱导细胞毒性[1]。 |
| Synonyms | GEN3013 |
| molecular weight | N/A |
| CAS | 2134641-34-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |